Sep 03, 2013 1:38pm EDT Can-Fite to Present at Rodman & Renshaw Global Investment Conference on September 9, 2013
Aug 28, 2013 11:12am EDT Can-Fite to Initiate a Phase II Study With CF102 in 130 Patients With Advanced Liver Cancer
Nov 13, 2012 10:00am EST Can-Fite BioPharma to Develop a Drug for the Treatment of Sexual Dysfunction
Oct 09, 2012 12:00am EDT Interim Analysis Supports Continuation of Can-Fite's Phase 2/3 Psoriasis Clinical Study with CF101
